As of 2025-03-16, the Relative Valuation of Abivax SA (ABVX.PA) is (30.09) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 5.46 EUR, the upside of Abivax SA based on Relative Valuation is -651.2%.
The range of the Relative Valuation is (30.74) - (26.54) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 17.1x | 16.3x |
| Forward P/E multiples | 4.3x - 9.5x | 5.2x |
| Fair Price | (30.74) - (26.54) | (30.09) |
| Upside | -663.0% - -586.0% | -651.2% |
| Date | P/E |
| 2025-03-06 | -2.74 |
| 2025-03-05 | -2.48 |
| 2025-03-04 | -2.35 |
| 2025-03-03 | -2.46 |
| 2025-02-28 | -2.48 |
| 2025-02-27 | -2.64 |
| 2025-02-26 | -2.54 |
| 2025-02-25 | -2.56 |
| 2025-02-24 | -2.62 |
| 2025-02-21 | -2.73 |
| 2025-02-20 | -2.63 |
| 2025-02-19 | -2.39 |
| 2025-02-18 | -2.44 |
| 2025-02-17 | -2.34 |
| 2025-02-14 | -2.43 |
| 2025-02-13 | -2.38 |
| 2025-02-12 | -2.25 |
| 2025-02-11 | -2.28 |
| 2025-02-10 | -2.26 |
| 2025-02-07 | -2.04 |
| 2025-02-06 | -2.08 |
| 2025-02-05 | -2.03 |
| 2025-02-04 | -2.09 |
| 2025-02-03 | -2.09 |
| 2025-01-31 | -2.16 |
| 2025-01-30 | -2.10 |
| 2025-01-29 | -2.10 |
| 2025-01-28 | -2.12 |
| 2025-01-27 | -2.16 |
| 2025-01-24 | -2.18 |
| 2025-01-23 | -2.14 |
| 2025-01-22 | -2.21 |
| 2025-01-21 | -2.21 |
| 2025-01-20 | -2.23 |
| 2025-01-17 | -2.16 |
| 2025-01-16 | -2.18 |
| 2025-01-15 | -2.21 |
| 2025-01-14 | -2.16 |
| 2025-01-13 | -2.19 |
| 2025-01-10 | -2.31 |
| 2025-01-09 | -2.26 |
| 2025-01-08 | -2.41 |
| 2025-01-07 | -2.50 |
| 2025-01-06 | -2.50 |
| 2025-01-03 | -2.50 |
| 2025-01-02 | -2.60 |
| 2024-12-31 | -2.41 |
| 2024-12-30 | -2.39 |
| 2024-12-27 | -2.52 |
| 2024-12-24 | -2.53 |